I began my academic journey at the University of Salford during my undergraduate studies, graduating in May 2023. My time at Salford was marked by academic growth and a sense of belonging fostered by the university’s supportive environment. A pivotal influence during this time was the guidance of my dissertation module leader, whose mentorship inspired my passion for research and commitment to academic excellence. Their encouragement played a key role in my decision to pursue a PhD at Salford.
Currently, my PhD research focuses on the effect of alcohol exposure on the non-coding transcriptome and epi-transcriptome of human neuronal cells. The study explores how alcohol disrupts the regulatory functions of non-coding RNAs (ncRNAs) and epi-transcriptomic modifications, particularly through alterations in m6A methylation, a key mechanism in regulating gene expression. Alcohol-induced changes in m6A methylation affect mRNA stability, translation, and splicing, significantly impacting neuronal development. Furthermore, disruptions in ncRNAs, such as microRNAs (miRNAs), contribute to cognitive and behavioral deficits associated with prenatal alcohol exposure, a major factor in Fetal Alcohol Spectrum Disorders (FASD). My research aims to identify biomarkers reflecting these disruptions, advancing the understanding and prevention of FASD.
Beyond academia, I bring real-world experience as a research scientist with Carigenetics, a Bermuda-based company specialising in epigenetic research. Over the past year, I have contributed to a groundbreaking breast cancer study, collaborating with esteemed professionals, and expanding my expertise in genetic and epigenetic mechanisms in disease. My contributions to this work will be recognized in a forthcoming publication, reflecting my dedication and commitment to impactful research.
As a proud member of Salford’s research community, I am excited to continue contributing to the university’s legacy of innovation and academic excellence.